Document is current
Any future updates will be listed below
-
Authors
Nhassengo, Pedroso
Atkins, Salla
Nhamuave, Celina
Uanela, Miguel
Matusse, Cristovão
Banze, Denise
Maphossa, Vânia
Hirasen, Kamban
Ivanova, Olena
Evans, Denise
Lönnroth, Knut
Khosa, Celso
Wingfield, Tom
- License Information
-
More Information
Article History
Received: 3 February 2024
Accepted: 13 March 2025
First Online: 10 April 2025
Declarations
:
: The study was carried out following the TB Sequel study protocol,(26) the Declaration of Helsinki (last updated in October 2013), and the WHO Handbook for Good Clinical Research Practice (July 2002). The TB Sequel protocol received approval from the Mozambican National Bioethics Committee (IRB00002656—Comité Nacional de Bioética para a Saúde/CNBS, Reference number: 291/CNBS/2017) and in all other countries implementing the study (South Africa, Tanzania, and The Gambia). Before participating in the study, all participants were provided with clear and comprehensive information about the procedures and gave their written informed consent. A unique participant identification number (Participant ID) was assigned to each participant to identify their data as study documents did not contain any identifying information to ensure participant confidentiality.
: Not applicable.
: The authors declare no competing interests.
